rapid
pace
sever
acut
respiratori
syndrom
coronaviru
pandem
present
challeng
robust
collect
populationscal
data
address
global
health
crisi
establish
coronaviru
pandem
epidemiolog
cope
consortium
bring
togeth
scientist
expertis
big
data
research
epidemiolog
develop
symptom
tracker
mobil
applic
launch
uk
march
us
march
garner
million
user
date
mobil
applic
offer
data
risk
factor
herald
symptom
clinic
outcom
geograph
hot
spot
initi
offer
critic
proofofconcept
repurpos
exist
approach
enabl
rapidli
scalabl
epidemiolog
data
collect
analysi
critic
datadriven
respons
public
health
challeng
exponenti
increas
number
sever
acut
respiratori
syndrom
coronaviru
infect
led
urgent
need
expand
public
health
activ
elucid
epidemiolog
novel
viru
character
potenti
impact
understand
risk
factor
infect
predictor
subsequ
outcom
critic
gain
control
coronaviru
diseas
pandem
howev
speed
pandem
unfold
pose
unpreced
challeng
collect
exposur
data
character
full
breadth
diseas
sever
hamper
effort
dissemin
accur
inform
time
manner
impact
public
health
plan
clinic
manag
thu
urgent
need
adapt
realtim
datacaptur
platform
rapidli
prospect
collect
action
highqual
data
encompass
spectrum
subclin
acut
present
identifi
dispar
diagnosi
treatment
clinic
outcom
address
prioriti
allow
accur
estim
diseas
incid
inform
risk
mitig
strategi
effect
alloc
stillscarc
test
resourc
allow
appropri
quarantin
treatment
afflict
evolv
bodi
literatur
suggest
incid
outcom
vari
accord
age
sex
raceethn
underli
health
statu
inconsist
evid
suggest
commonli
use
medic
angiotensinconvert
enzym
ace
inhibitor
thiazolidinedion
tzd
ibuprofen
may
alter
natur
diseas
cours
symptom
vari
wide
fever
dri
cough
reportedli
preval
though
numer
investig
demonstr
asymptomat
carriag
signific
determin
commun
spread
addit
full
spectrum
clinic
present
still
character
may
significantli
differ
differ
patient
group
evidenc
recent
advisori
american
gastroenterolog
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
associ
aga
american
academi
otolaryngolog
head
neck
surgeri
aaohn
british
geriatr
societi
bg
potenti
import
previous
underappreci
gastrointestin
symptom
eg
nausea
anorexia
diarrhea
loss
tast
andor
smell
associ
infect
well
common
geriatr
syndrom
eg
fall
delirium
pandem
dramat
outpac
collect
effort
fulli
character
atrisk
may
suffer
seriou
sequela
infect
mobil
phone
applic
webbas
tool
facilit
selfguid
collect
populationlevel
data
scale
result
rapidli
redeploy
inform
particip
urgent
health
inform
particularli
advantag
threequart
american
advis
physic
distanc
digit
tool
alreadi
use
control
research
set
benefit
greater
lead
time
field
test
question
curat
recruit
although
sever
digit
collect
tool
symptom
develop
launch
us
includ
partnership
govern
health
agenc
cdc
applic
larg
configur
offer
singl
assess
symptom
tailor
recommend
evalu
altern
other
develop
research
report
patientlevel
inform
behalf
particip
alreadi
enrol
clinic
registri
approach
offer
critic
public
health
insight
tailor
type
scalabl
longitudin
data
captur
epidemiologist
need
perform
comprehens
wellpow
investig
address
public
health
crisi
meet
challeng
establish
intern
collabor
coronaviru
pandem
epidemiolog
cope
consortium
compris
lead
investig
sever
larg
clinic
epidemiolog
cohort
studi
cope
bring
togeth
multidisciplinari
team
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
scientist
expertis
big
data
research
translat
epidemiolog
interrog
pandem
largest
divers
patient
popul
assembl
todat
sever
larg
incept
cohort
alreadi
agre
join
effort
includ
nurs
health
studi
ii
grow
today
studi
health
profession
followup
studi
twinsuk
cancer
prevent
studi
multiethn
cohort
aid
data
harmon
effort
codevelop
symptom
tracker
mobil
app
partnership
inkind
contribut
zoe
global
ltd
digit
healthcar
compani
academ
scientist
king
colleg
london
leverag
establish
digit
backbon
applic
use
person
nutrit
studi
covid
symptom
tracker
launch
uk
march
garner
user
day
sinc
launch
launch
app
us
even
march
covid
symptom
tracker
enabl
selfreport
data
relat
exposur
infect
fig
first
use
app
queri
locat
age
core
health
risk
factor
daili
prompt
queri
updat
interim
symptom
health
care
visit
test
result
selfquarantin
seek
health
care
level
intervent
relat
outcom
collect
individu
without
obviou
symptom
also
encourag
use
app
push
softwar
updat
add
modifi
question
realtim
test
emerg
hypothes
symptom
treatment
importantli
particip
enrol
ongo
epidemiolog
studi
clinic
cohort
clinic
trial
provid
inform
consent
link
survey
data
collect
app
health
insur
portabl
account
act
hippa
gener
data
protect
regul
gdpr
compliant
manner
preexist
studi
cohort
data
relev
biospecimen
specif
modul
also
provid
particip
identifi
healthcar
worker
determin
intens
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
type
direct
patient
care
experi
avail
use
person
protect
equip
ppe
workrel
stress
anxieti
rapid
deploy
tool
gain
critic
insight
popul
dynam
diseas
fig
collect
participantreport
geospati
data
highlight
critic
need
pandem
epidemiolog
research
rapidli
identifi
popul
highli
preval
symptom
may
emerg
hot
spot
outbreak
preliminari
snapshot
first
million
user
uk
first
five
day
use
confirm
variabl
symptom
report
across
suspect
case
use
gener
test
broader
hypothes
user
mean
age
rang
year
femal
user
simpl
visual
initi
result
fig
demonstr
among
report
symptom
march
common
symptom
fatigu
cough
follow
diarrhea
fever
anosmia
short
breath
rel
rare
report
individu
report
possibl
symptom
report
receiv
qpcr
test
among
individu
undergo
test
cough
fatigu
alon
combin
commonli
led
test
highli
predict
posit
test
similarli
individu
report
diarrhea
absenc
symptom
test
posit
interestingli
complex
present
cough
andor
fatigu
least
one
addit
symptom
includ
less
commonli
appreci
symptom
diarrhea
anosmia
appear
better
predictor
particular
anosmia
may
sensit
symptom
common
fever
individu
test
posit
contrast
fever
alon
particularli
discriminatori
howev
combin
lesser
appreci
symptom
greater
frequenc
posit
test
observ
find
suggest
individu
complex
symptomat
present
perhap
priorit
test
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
concerningli
individu
report
complex
symptom
cough
andor
fatigu
plu
least
one
anosmia
diarrhea
fever
yet
receiv
test
repres
substanti
popul
appear
greater
risk
diseas
addit
data
collect
appli
machin
learn
bigdata
approach
identifi
novel
pattern
emerg
dynam
set
exposur
onset
symptom
diseas
trajectori
clinic
outcom
launch
app
within
sever
larg
epidemiolog
cohort
previous
gather
longitudin
data
lifestyl
diet
health
factor
genet
inform
allow
investig
much
broader
rang
put
risk
factor
outcom
addit
followup
also
uniqu
posit
investig
longterm
outcom
includ
mental
health
disabl
mortal
effect
beyond
infect
includ
work
hazard
ppe
shortag
emot
stress
absente
realtim
data
gener
focus
within
popul
critic
optim
alloc
resourc
protect
healthcar
workforc
assess
efficaci
near
futur
hope
releas
app
fairus
open
sourc
softwar
allow
translat
develop
region
also
develop
practic
toolkit
clinic
research
facilit
local
institut
review
board
irb
regulatori
approv
facilit
use
within
research
studi
wwwmonganinstituteorgcopeconsortium
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
toolkit
includ
full
detail
question
ask
within
app
consent
document
privaci
polici
term
use
mobil
app
believ
novel
approach
demonstr
critic
proofofconcept
rapid
repurpos
exist
data
collect
approach
implement
scalabl
realtim
collect
populationlevel
data
fastmov
global
health
crisi
nation
emerg
call
upon
colleagu
work
us
may
deploy
tool
dispos
address
unpreced
public
health
challeng
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
proport
popul
report
complex
symptom
wherea
area
lowcomplex
symptom
preval
receiv
higher
rate
test
consequ
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
neg
test
green
map
exampl
realtim
visual
data
captur
covid
symptom
tracker
may
assist
public
health
govern
offici
realloc
resourc
identifi
area
unmet
test
need
detect
emerg
hot
spot
earlier
particip
provid
data
whether
test
test
result
individu
report
receiv
test
symptom
symptom
frequenc
among
test
posit
upper
right
vs
neg
lower
right
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
